#bioinformatics solutions
Explore tagged Tumblr posts
Text
Unlock breakthroughs with Excelra's bioinformatics solutions
Excelra is a pioneering life science company at the forefront of innovation, offering cutting-edge bioinformatics solutions. With our expertise and advanced technology, we empower researchers and organizations to unlock the potential of biological data for transformative discoveries.
1 note
·
View note
Note
Hi there! I hope this doesn’t sound antagonistic (I’m not trying to be, just playing the devils advocate. Also, my background is more in bioinformatics, so I’m not sure if that counts as “layman” or not, but I do handle a lot of data and databases) but a lot of blowback regarding AI stuff is the sheer desperation a lot of artist feel regarding the scraping of art. Work really has dried up for many artists directly as a result from AI, and it doesn’t help a lot of studios have been laying off people. The people at the working at Nightshade and Glaze understand it’s not a perfect tool or solution, but, like they clarified before, it does provide some friction and it’s still being worked on. Personally, I would also like some of the energy directed to making some legislation happened, but it’s going to take time and a concerted movement before that happens.
May I ask what are your thoughts on this? I would love to hear more from you! I think most of the time people act rashly is from desperation more than stupidity.
any "legislation" around AI art would take the form of corporations using this as an opportunity to expand IP and copyright law in ways that would only benefit them (corporations) and directly harm everyone else, including independent artists
the Luddites were wrong
57 notes
·
View notes
Text
oops! i did it again. lessons from this school year...


Hey, you remember that post I made about my winter term priorities? HAHAHAHAHahaha ha ha. That plan totally went to shit, but it's all part of the journey, right? 😅 (Tbh, it's quite difficult to make a conscious effort to change yourself when the default response to being and feeling busy is to go on autopilot -> all the unconscious habits, even if unhealthy, take control, and bc it's unconscious, you don't realize it until it gets quite bad! anyway! no more! my future plans make it so this will be impossible to do while still retaining some sense of sanity. so to prep, we're gonna slowly implement little changes so hopefully it's not so overwhelming that i give up)
🧘🏻♀️ comparing mindsets in fall and winter term
Fall term was not that bad bc I had 2 STEM subjects I really really loved and was interested in (biochem and mol bio 💕), and despite their difficulty, that love and interest and the feeling that "I am in the right field for me" kept me positive. There were times I thought I would feel burnout symptoms if I wasn't careful, but I really think that positivity protected me from the worst of it.
Winter term, however...I had one favorite subject: moral philosophy, which led to me wistfully dreaming about an AU in which I double majored in philosophy and piano performance, lol. After the highs of biochem and mol bio and the natural ease with which the bits of info flowed together in those subjects, I did not enjoy pharmacology or the 2nd half of psyc as much -> loss of interest -> negativity and feeling like I'm in the wrong field bc how dare I not like pharmacology (or psychology) as much as the other life science-y subjects when it's really so important for us to survive and thrive! 😅 I mean, there were times I could get that spark from pharmacology or psyc, but it wasn't often enough or intense enough to keep me consistently inspired throughout the semester. The feeling of "maybe I don't have what it takes and I'm in the wrong field" was compounded by the re-realization that there's sm to know of bioinformatics and I struggle to know any of it! Persevering is important, but it's harder to persevere with a negative mindset.
😤 what went wrong this school year and what i learned from it
I still struggle with perfectionism (and bc of it, procrastination). While it might not be as bad as it was in high school, I still spent too long on assignments that weren't worth much and during finals season, was so scared of getting less than 90% just to keep up my A+ streak. Like, I'm pretty sure no one who cares to know your GPA cares about whether you have an A+ streak or not. I have too high a threshold for what is a "disappointing" grade. I also struggle with deep regret about how I haven't mastered everything they throw at us in each course... definitely an unrealistic expectation, especially as the proportion of new info to absorb increases with each course. I did what I could using what I knew to do, so it is what it is. I may find ways to make improvements and learn more, but I won't beat myself up for not having known to do those things in the past.
Did not use effective study methods. Since first year, my problem has been keeping up with the readings and my solution has been to just use typed outline notes. It worked for the first few years when it was mostly review from previous courses with a few new concepts in between. But as I progress through my degree, the proportion of completely new info is increasing. This notetaking method won't work anymore bc it just causes cognitive overload, especially during exam season (when I've mostly forgotten the details of everything that isn't smth I've already known for years). E.g. for pharmacology, I got so bogged down by the details of all the drug classes that I didn't see the big picture and so didn't organize the info according to it. This made it hard to see patterns and better chunk the info. I was so stressed during finals season bc of this (and the sheer amount of notes that I had to read for psyc 😭). What makes it feel like even more of a problem is that the cognitive overload problem from my notetaking method has been a thing for all other uni courses thus far, it's just that pharmacology was the first time I needed to create a stronger connecting thread between the otherwise disparate pieces of info (drug classes). In all other courses, that thread was part of the nature of the topic being studied so I eventually understood it as I kept going and mentally re-organized it in my brain...but even then it was hodge-podge and so my depth of mastery was and is so flimsy, and every semester I leave feeling drained and like I wasted the opportunity to maximize my learning. (How dramatic I get about this is also probably tied to my perfectionism, but I still think it would greatly benefit future me to change my notetaking style.)
🎓 advice for future me
Look at the academic calendar, specifically the faculty course descriptions. Look at how many hours they say you should expect to spend on each activity in the course. Try to use those learning hours as a guide for your schedule so that you don't spend too long on an item that isn't worth much. If there isn't such a breakdown, assume one based on whatever they give you or other courses and adjust from there.
Be a more efficient reader by skimming the text first so you can map the flow of info in a way that best creates ease of understanding/synthesis/memory (e.g. via an outline, tree diagram, flowchart, mind map, or simple drawings - and noticing when a list/outline will NOT be helpful bc it'll just be too overwhelming and not easy to compare/contrast info and see patterns). I knowww you've survived thus far without doing it this way and done well, BUT with this many courses, the increasing complexity of each subject, and the overload of info in each, you WILL need to do this to make quicker work of the readings, save you sooo much stress during exam seasons, and improve how much you learn while in school which is the real goal you've wanted to achieve all this time. Don't repeat the mistake you made in pharmacology. And it really doesn't have to be aesthetic and you definitely should NOT get caught up with it if you really wanna learn. You could just use one color for everything and a highlighter and just basic shapes/lines - that alone can be way more effective than boring paragraphs/lists or a colorful, overly complex diagram that'll just distract you from the main point.
Create a realistic daily routine (wake-up and sleep times, start and end times for schoolwork) and be strict about following it. Set your non-negotiables for personal goals to keep up with alongside your schoolwork bc academics aren't everything. Remember how you regretted not devoting more time to extra-curriculars and other skills in high school which would've rounded you out as a person. You can try theming the parts of the day so that you don't have to think about what task you should do first after study breaks and keep up the momentum (e.g. mornings for readings and notes, afternoons for active recall/homework). Then you can live the rest of the day after school as structured or unstructured as you wish. If this strategy doesn't work for you, you don't have to use it.
Take advantage of interleaving so you don't get bored. Whether by following the theming strategy or just switching subjects every hour, idc if you aren't done yet, you better switch bc the second consecutive hour of the same thing is never as effective as the first.
#studyblr#studyspo#study motivation#becoming that girl#pink aesthetic#study tips#study advice#personal post#100dop#100 days of productivity#stemblr#stem academia#stem student#100 days of studying#100 days of self discipline#perfectionism#study strategies#mental health#chaotic academia
22 notes
·
View notes
Text
Unveiling Java's Multifaceted Utility: A Deep Dive into Its Applications
In software development, Java stands out as a versatile and ubiquitous programming language with many applications across diverse industries. From empowering enterprise-grade solutions to driving innovation in mobile app development and big data analytics, Java's flexibility and robustness have solidified its status as a cornerstone of modern technology.
Let's embark on a journey to explore the multifaceted utility of Java and its impact across various domains.
Powering Enterprise Solutions
Java is the backbone for developing robust and scalable enterprise applications, facilitating critical operations such as CRM, ERP, and HRM systems. Its resilience and platform independence make it a preferred choice for organizations seeking to build mission-critical applications capable of seamlessly handling extensive data and transactions.
Shaping the Web Development Landscape
Java is pivotal in web development, enabling dynamic and interactive web applications. With frameworks like Spring and Hibernate, developers can streamline the development process and build feature-rich, scalable web solutions. Java's compatibility with diverse web servers and databases further enhances its appeal in web development.
Driving Innovation in Mobile App Development
As the foundation for Android app development, Java remains a dominant force in the mobile app ecosystem. Supported by Android Studio, developers leverage Java's capabilities to craft high-performance and user-friendly mobile applications for a global audience, contributing to the ever-evolving landscape of mobile technology.
Enabling Robust Desktop Solutions
Java's cross-platform compatibility and extensive library support make it an ideal choice for developing desktop applications. With frameworks like Java Swing and JavaFX, developers can create intuitive graphical user interfaces (GUIs) for desktop software, ranging from simple utilities to complex enterprise-grade solutions.
Revolutionizing Big Data Analytics
In big data analytics, Java is a cornerstone for various frameworks and tools to process and analyze massive datasets. Platforms like Apache Hadoop, Apache Spark, and Apache Flink leverage Java's capabilities to unlock valuable insights from vast amounts of data, empowering organizations to make data-driven decisions.
Fostering Innovation in Scientific Research
Java's versatility extends to scientific computing and research, where it is utilized to develop simulations, modeling tools, and data analysis software. Its performance and extensive library support make it an invaluable asset in bioinformatics, physics, and engineering, driving innovation and advancements in scientific research.
Empowering Embedded Systems
With its lightweight runtime environment, Java Virtual Machine (JVM), Java finds applications in embedded systems development. From IoT devices to industrial automation systems, Java's flexibility and reliability make it a preferred choice for building embedded solutions that require seamless performance across diverse hardware platforms.
In summary, Java's multifaceted utility and robustness make it an indispensable tool in the arsenal of modern software developers. Whether powering enterprise solutions, driving innovation in mobile app development, or revolutionizing big data analytics, Java continues to shape the technological landscape and drive advancements across various industries. As a versatile and enduring programming language, Java remains at the forefront of innovation, paving the way for a future powered by cutting-edge software solutions.
2 notes
·
View notes
Text
Crowdsourcing: not a new concept

what is crowdsourcing?
By using the Internet, social media, and smartphone apps, a huge number of individuals can contribute their work, information, or opinions through a process known as crowdsourcing.
While some crowdsourcing participants carry out menial jobs willingly, others work as paid freelancers. For instance, in order to give app users access to up-to-date, real-time information, traffic applications such as Waze incentivize drivers to self-report accidents and other traffic occurrences. (Hargrave, 2022) Crowdsourcing is a collaborative approach that involves sourcing information, ideas, or services from a wide and diverse group of individuals, known as the "crowd." This decentralized method relies on the collective intelligence and varied expertise of contributors, often facilitated through online platforms. Crowdsourcing is characterized by an open call for participation, inviting individuals to provide solutions, ideas, or content to address specific challenges or tasks.
Crowdsourcing in crisis
Amid the global, ongoing COVID-19 pandemic, among the tireless work of health care workers, policy makers, and government officials across various nations, there is another player with “skin in the game” if you will—crowdsourcing projects. Crowdsourcing is a model whereby individuals or organizations obtain goods and services, including ideas, from a large, relatively open community of digital media, Internet users, and an entire array of diverse stakeholders sharing a common interest from a range of perspectives and experiences.1 Although crowdsourcing originated long before the advent of digital age, in the current era of social media and other digital outlets, crowdsourcing has become a fairly commonplace solution. (Desai, 2020) Crowdsourcing in health and medical mostly started in the bioinformatics and technology fields about 2010. Its broad usefulness in disaster crisis management has, however, mostly gone unutilized. We address the ongoing and present uses of crowdsourcing in the COVID-19 era from this point of view. The COVID-19 pandemic, which has infected > 5 million people worldwide and caused > 330,000 deaths at the time of this writing, is no less than a disaster crisis, albeit biological. A disaster life cycle consists of the steps taken in planning for and responding to a particular disaster (Fig 1). This disaster cycle is used throughout the emergency management community, from the local to the national and international levels. We saw similar disaster mitigation (social distancing), preparedness (quarantine restrictions), response (masking), and recovery efforts during the 1918-1920 seasonal H1N1 flu pandemic. (Kuderer, 2020)
Community for creatives
Crowdsourcing funding for projects, businesses, and causes is expected to grow to be a $300 billion industry in the near future, according to estimations made by the crowdfunding trends blog Fundly. In 2017, Stanford University student Nicholas Benavides, the creator of the Blue Ocean Entrepreneurship Competition for Students, conducted an analysis of over 2,000 Kickstarter project data to identify the elements of a successful crowdfunding campaign. Benavides surveying the terms used in a campaign's title and blurb using the Kaggle Kickstarter dataset developed a model that could predict a campaign's success with 75% accuracy. (Sickler, 2020) Among his major findings was that the most common words–game, new, design, world–appeared equally in both funded and unfunded campaigns. The major point of differentiation was not in word choice but between those categories inherently more social in nature, such as Comics, Dance, Music, Theater and Design, and solo practices like Craft and Journalism. Social categories were simply a more natural fit for the success criteria of crowdfunding.
Role of crowdsourcing in Web3
Crowdsourcing in Web3 refers to the decentralised process of obtaining goods or services from a large, undefined group of people via the internet, rather than from traditional employees or suppliers. The role of crowdsourcing in Web3 is to empower individuals and communities to collaborate and contribute their skills, knowledge, and resources to create and maintain decentralised applications and services that are more equitable, transparent, and secure. This can lead to increased innovation, collaboration, and democratisation in the development and deployment of new technologies, as well as in the creation of new forms of governance and value exchange. (Reffell, 2023)
Crowdsourcing in Web3 examples:-
DAOs: Decentralised autonomous organisations (DAOs) are organisations that are run through rules encoded as computer programs on a blockchain network. DAOs are governed by their members, who vote on proposals and make decisions collectively. Examples of DAOs include MakerDAO and Aragon.
Prediction Markets: Prediction markets are decentralised platforms that allow users to make predictions on the outcome of events and earn rewards for accurate predictions. Examples of prediction markets include Augur and Gnosis
Decentralised Exchanges (DEXs): Decentralised exchanges are platforms for trading cryptocurrencies and tokens without the need for a central authority or intermediaries. Examples of DEXs include Uniswap and Curve.
Decentralised Identity Systems: Decentralised identity systems are platforms that allow users to control and manage their personal information and data, rather than relying on central authorities or intermediaries. Examples of decentralised identity systems include Sovrin and uPort.
In conclusion, by utilising the combined knowledge of many participants, crowdsourcing has the potential to revolutionise creativity and problem-solving. Its capacity to combine a variety of viewpoints and abilities not only encourages innovation but also offers an economical way to address difficult problems. Its attractiveness stems from the speed at which solutions are generated and the active participation of communities, which fosters the growth of unorthodox ideas. But obstacles like upholding quality control and handling moral issues like equitable recompense and privacy issues highlight the necessity of cautious execution. With the integration of intelligent algorithms and automation in technology, crowdsourcing looks to have a bright future ahead of it, providing even more effective and significant collaboration in a variety of disciplines.
REFERENCE
Desai, A., Kuderer, N. M., & Lyman, G. H. (2020). Crowdsourcing in crisis: Rising to the occasion. JCO Clinical Cancer Informatics, (4), 551–554. https://doi.org/10.1200/cci.20.00054
Hargrave, M. (n.d.). Crowdsourcing: Definition, how it works, types, and examples. Investopedia. https://www.investopedia.com/terms/c/crowdsourcing.asp#:~:text=While%20crowdsourcing%20often%20involves%20breaking,samples%20for%20a%20small%20fee.
Reffell, C. (2023, February 7). What is the role of crowdsourcing in web3?. Crowdsourcing Week. https://crowdsourcingweek.com/blog/crowdsourcing-in-web3/#:~:text=Crowdsourcing%20in%20Web3%20is%20made,transactions%20and%20interactions%20between%20participants.
Sickler, E., & Erin Sickler Erin Sickler is a mindfulness & creativity coach living in the Hudson Valley. A former NY art curator. (2020, September 2). How to launch a Creative Crowdfunding Campaign for your next art project. art journal. https://artrepreneur.com/journal/creative-crowdfunding-for-artists/#:~:text=A%20well%2Ddesigned%2C%20online%20crowdfunding,win%20you%20fans%20for%20life.
3 notes
·
View notes
Text
B.Tech Biotechnology: Course Details, Eligibility, Fees & Career Scope
BTech in Biotechnology is an interdisciplinary program that integrates biology, chemistry, and technology to develop innovative solutions in healthcare, agriculture, and the environment. Students gain expertise in genetic engineering, bioinformatics, and pharmaceutical development, preparing them for careers in research, industry, and academia while contributing to advancements in sustainable practices and medical advancements. Check here to learn more.
0 notes
Text
Market Outlook for Rare Disease Genetic Testing

Rare disease genetic testing involves the use of advanced diagnostic techniques to identify genetic mutations associated with rare diseases. These tests analyze a patient's genetic material to detect mutations that could lead to conditions such as rare hereditary disorders, genetic syndromes, and other conditions that affect a small proportion of the population. The tests are critical for early diagnosis, personalized treatment plans, and understanding the genetic basis of rare diseases, ultimately improving patient outcomes.
The rare disease genetic testing market was valued based on a 2024 base year and is projected to grow at an approximate CAGR of 13% during the forecast period from 2025 to 2035. This growth is driven by advancements in genetic testing technologies and increasing demand for early, accurate diagnosis.
Market Demand
Developments in Technology: The speed, accuracy, and affordability of genetic testing have significantly increased due to rapid advancements in diagnostics, specifically in next-generation sequencing (NGS), targeted gene panels, and AI-enabled interpretation tools. These developments are expanding the use of genetic insights in drug discovery and personalized medicine, enabling earlier diagnosis, and enhancing clinical decision-making.
Growing Rates of Genetic Conditions: The need for high-precision diagnostic techniques is growing as congenital and hereditary disorders are becoming more prevalent worldwide. Demand is being driven and access to genetic testing is being extended across regions by initiatives like tailored medicine, larger testing programs, more money for research, and supporting regulatory frameworks.
Focus on Early Detection in Pediatrics: Early rare illness detection and prevention are becoming more and more important, particularly for young patients. Demand for genetic testing solutions is being fueled and acceptance is rising due to increased knowledge, expanded testing programs, better insurance coverage, and supportive healthcare legislation.
Industrial Impact
The market for genetic testing for uncommon diseases is essential to the transformation of contemporary healthcare. Timely therapies, better prognoses, and efficient resource allocation for patients and providers are all made possible by early and precise diagnosis. As more patients, doctors, and healthcare systems incorporate genetic insights into care pathways, the industry is emerging as a key component of precision medicine.
Market acceptance is being accelerated by global initiatives centered on rare illness awareness and research, shorter test turnaround times, and increased patient accessibility. Genetic testing is therefore improving clinical trials and population-level health policies in addition to improving individual care.
Recent Developments
In April 2023, Agilent Technologies, Inc. and Theragen Bio collaborated in South Korea to enhance bioinformatic solutions for cancer genomic profiling, further advancing precision medicine.
In April 2023, 3billion received accreditation from the California Department of Public Health (CDPH) as a clinical laboratory. With this accreditation, hospitals across California can now utilize 3 billion's rare disease genetic testing services for diagnostics and claim insurance coverage for these tests.
In February 2023, Akili Labs and BGI Genomics established the first commercial clinical sequencing facility in Africa, strengthening access to rare disease genetic testing and advanced genomic diagnostics in the region.
In January 2023, Premier Research and CENTOGENE formed a strategic partnership to accelerate and reduce the risk of clinical development for rare diseases, facilitating advancements in rare disease genetic testing and therapeutic research.
In February 2023, Illumina introduced the first NovaSeq X Plus sequencer and unveiled workflow insights on Illumina Complete Long Reads at the Advances in Genome Biology and Technology (AGBT) conference, supporting advancements in genomic sequencing and rare disease genetic testing.
In March 2023, Invitae announced a partnership with Epic to streamline rare disease genetic testing through Aura, Epic’s specialty diagnostics suite. This collaboration aims to integrate genetic test results seamlessly into provider workflows, making genetic insights more accessible for informed treatment decisions.
Gain a comprehensive market overview from industry experts and unlock valuable insights to drive your business growth. Download our sample now!
Want to learn more about Healthcare Vertical. Click Here!
Conclusion
The market for genetic testing for rare diseases is expanding rapidly due to a combination of clinical demand, innovation, and supportive legislation. As AI and next-generation sequencing technologies advance, they are opening the door to testing solutions that are more precise, quick, and easily accessible.
The diagnostic gap is being filled in part by increased knowledge of genetic diseases, especially in pediatric populations, better reimbursement schemes, and government-supported health programs. Collectively, these developments are changing the way rare illness care is provided, enabling early interventions, directing the creation of new treatments, and eventually improving patient outcomes globally.
#rare disease genetic testing market#rare disease genetic testing industry#rare disease genetic testing report#health#healthcare
0 notes
Text

Powering the Future of Scientific Research with GPUs
Accelerate innovation with GPU servers built for high-performance computing in science, from climate modeling to bioinformatics and beyond.
📞 US Toll-Free No.: +1 888-544-3118 ✉️ Email: [email protected] 🌐 Website: https://www.gpu4host.com/ 📱 Call (India): +91-7737300013
🚀 Get in touch with us today for powerful GPU Server solutions!
0 notes
Text
A Day in the Life at Greenarray Genomics: Behind the Scenes at a Cutting-Edge Lab
Genetic testing may begin with a sample and end with a report, but between those two points lies an entire world of science, precision, and passion. At Greenarray Genomics Research and Solutions Pvt. Ltd., each day is a dynamic journey through the intricate layers of molecular diagnostics, cytogenetics, and clinical research.
Step inside our state-of-the-art lab in Pune and experience what a typical day looks like behind the scenes — where genetic data meets human dedication.
☀️ 8:30 AM – Starting with Sterility and Structure
The day begins with our team of lab technologists, molecular biologists, and cytogeneticists suiting up in sterile gear — coats, gloves, caps. First up is equipment calibration and quality checks, ensuring every sequencer, incubator, and PCR machine is operating at peak precision.
“Clean environment and equipment validation come first. In genetics, even the smallest contaminant can skew results.” — Shruti, Senior Lab Technician
🧪 9:30 AM – Sample Arrival and Registration
Samples from hospitals, clinics, and direct clients start arriving — amniotic fluid for prenatal testing, blood samples for thalassemia screening, buccal swabs for hereditary cancer panels, and more.
Our accessioning team registers each sample, assigning it a unique barcode and logging it into the Laboratory Information Management System (LIMS). Every sample’s journey is now traceable — from extraction to analysis.
🔬 10:00 AM – DNA Extraction & Cytogenetic Culturing
In two different wings of the lab, parallel activities unfold:
In the molecular lab, DNA is being extracted using automated platforms to ensure high-quality yield — the starting point for accurate genetic analysis.
In the culture center, fetal and tumor cells are gently nurtured in incubators. Our cytogenetics team monitors cell growth, preparing slides for karyotyping and FISH (Fluorescence In Situ Hybridization) analysis.
“Each cell culture has its personality — some grow fast, some need extra care. We’re patient, because the diagnosis depends on it.” — Dr. Prajakta, Cytogenetics Head
🧬 12:00 PM – NGS Prep and Sequencing Runs
It’s time for Next Generation Sequencing (NGS). Our bioinformaticians and molecular technologists prepare DNA libraries for sequencing. Samples are placed into high-throughput sequencers, which begin decoding millions of DNA fragments in parallel.
Real-time monitoring ensures data quality, while controls and replicates validate every run.
💻 3:00 PM – Bioinformatics & Data Analysis
Once sequencing is complete, terabytes of raw data flow into our bioinformatics servers. Now the digital detectives take over — aligning sequences, identifying mutations, and filtering out false positives using AI-assisted pipelines.
Reports are generated, reviewed by geneticists, and interpreted in a clinical context. Is this BRCA mutation pathogenic? Could this CNV explain a child’s developmental delay? These are questions we answer with science and sensitivity.
📞 5:00 PM – Reporting & Genetic Counseling
Reports are dispatched to clinicians, hospitals, and patients, often accompanied by genetic counseling sessions. We take time to explain the meaning behind every variant — whether it’s actionable, inherited, or of uncertain significance.
“We don’t just give test results. We help people understand their health, their families, and their future.” — Dr. Sanjay Gupte, Founder & Director
🌙 6:30 PM – Winding Down, Preparing for Tomorrow
As the lab winds down, teams clean and sterilize workspaces, back up data, and prepare for the next batch of samples. Quality assurance teams review logs, ensuring every protocol was followed — because consistency builds trust.
🚀 More Than a Lab — A Mission
At Greenarray Genomics, we don’t just perform tests — we solve puzzles, enable prevention, and empower care. Every day here is a reminder that behind every tube is a story, a family, a decision that matters.
So whether we’re decoding rare disorders, aiding prenatal care, or supporting cancer treatment, our mission remains clear: Deliver accurate, timely, and compassionate genetic insights — with integrity and innovation.
0 notes
Text
"Bioinformatic Transduction"
To be or not to be, that is the question.
For if being is without a doubt what we are, why do we doubt it?
In a multitude of beings ever so present, how is it that we struggle with sentience and a coexisting benevolence?
Today, I grasp the inescapable. Open your mind just gently, to consider my thoughts.
Science matters to determine patterns, behaviors, and existence. Computers persist with language, a code, if you will.
Consider the language of the universe for just a moment.
What comes to mind?
Silence, numbers, noises, maybe laughter, or cries.
There is no denying the universe is charged with sound, transmission, and language.
How it's perceived depends on what you are.
Not who.
What.
Are you human, part reptilian, a touch amphibian, a sloth, or maybe a cat?
How can you tell?
DNA.
This code in our bodies exists everywhere in nature.
Nature's code exists everywhere in our bodies.
The cyclical patterns of creation and evolution find their way forward no matter what…
bent by existence and sent for survival.
The difference between the us now and the us then is that we are no longer primal.
Or so we think...
The fact of the matter is... we have evolved and are evolving. Monks in the mountains, doctors, surgeons, scientists... all individually putting in at 2 times the effort of the average.
Evolving for us. Isn't it so?
We have the choice to pursue it, but many are unable.
So, I must raise the question.
Who is to deny the possibility of Bioinformatic Transduction?
A specialized combination of language, life-- leverage… the spiritualization of digitization.
The code of the universe, encrypted and converted into binary literature…
language illustrated by a device.
Conceived from the motion of ether and perception that is vision, to digit, then image.
Imagine
What I raise next is no cliche and is to be contemplated gently.
Is it real or fake? That isn't my concern.
Is life an illusion? Us being avatars, a conclusion?
That is not my entire argument.
What I bring to you is the thought, the reality of DNA entering a computer.
Its origin fully understood, its characteristics magnified, and its acclimation processed.
Ponder it.
Deeper...
Infinity exists on the other side of that thought, implicating the possibility of
induction through Bioinformatic Transduction.
A process of relocating matter dimensionally through light,
preserving all that it is made of.
Matrices made of life and semantic language.
Layered, paralleled, generating altered states of existence.
This is creation.
With gratitude,
Rayvon Mattison
Founder of YukosDream & Spirited Journey Solutions | Visionary | Author
www.spiritedjourneysolutions.io
Contact Me [email protected]
Thank you for reading.
May your thoughts expand, and actions be well.
#science-fiction#science#blog#creative writing#writers on tumblr#author#philosophy#writers#booklr#bookblr#books and literature#content creator#Viraether Creations#yukosdream#best selling books
0 notes
Text
BTech Biotech in Lucknow: Top Colleges, Curriculum & Career Scope
Biotechnology is at the forefront of innovation, merging biology with technology to develop solutions in healthcare, agriculture, and environmental science. If you're planning to pursue a BTech in Lucknow, particularly in biotechnology, you're stepping into a field with massive potential and real-world impact.
In this article, we’ll explore the Top BTech Biotechnology Colleges in Lucknow, the core curriculum, lateral entry options, and the career landscape that follows.
Why Choose BTech Biotechnology?
BTech in Biotechnology combines engineering principles with biological sciences to create technologies and products that help improve lives. It’s ideal for students passionate about science, genetics, research, and problem-solving. Unlike pure science courses, a BTech provides hands-on technical knowledge and makes you industry-ready from day one.
BTech in Lucknow: A Rising Education Hub
Lucknow has emerged as a serious player in the engineering education scene. With a mix of government-funded institutes and high-quality private colleges, the city offers affordable and accessible technical education.
For students seeking the best lateral entry BTech college in Lucknow, the options are growing each year. Lateral entry allows diploma holders to join BTech courses in the second year directly, which saves time and money while offering a streamlined pathway to engineering degrees.
Top BTech Biotechnology Colleges in Lucknow
If you're looking for the best BTech Biotech colleges in Lucknow, here are some of the top-ranked institutions to consider:
1. Integral University
One of the most reputed private universities in the region, Integral offers a robust BTech Biotechnology program. It has a dedicated School of Life Sciences, well-equipped labs, and research opportunities.
2. Amity University, Lucknow
Amity’s Lucknow campus offers a highly industry-oriented curriculum with strong faculty support, research exposure, and internship opportunities. Their focus on innovation gives students a competitive edge.
3. Babu Banarasi Das University (BBDU)
Known for its infrastructure and placement support, BBDU is a popular choice for students looking to specialize in biotech. The university often collaborates with biotech firms for guest lectures and projects.
4. Dr. A.P.J. Abdul Kalam Technical University (AKTU) Affiliated Colleges
AKTU governs several engineering colleges in Lucknow that offer BTech in Biotechnology. Some notable ones include Institute of Engineering and Technology (IET) and Shri Ramswaroop Memorial University.
These are among the Top BTech Biotechnology Colleges in Lucknow, offering not just strong academics but also research and career development support.
Curriculum Overview
The BTech Biotechnology curriculum is designed to provide a balance between theoretical understanding and practical application. Key subjects include:
Molecular Biology
Biochemistry
Genetic Engineering
Microbiology
Bioinformatics
Process Engineering
Plant and Animal Biotechnology
Biostatistics
Environmental Biotechnology
Students also work on live projects, undergo industrial training, and conduct final-year research work, which prepares them for real-world challenges.
Lateral Entry into BTech Biotech in Lucknow
If you've completed a diploma in biotechnology or a related stream, you may be eligible for lateral entry BTech in Lucknow. This route lets you join directly in the second year of the BTech program.
Some of the best lateral entry BTech colleges in Lucknow that offer biotechnology or allied branches include:
Ambalika Institute of Management & Technology
Saroj Institute of Technology & Management
Shri Ramswaroop Memorial Group of Professional Colleges
These colleges typically conduct an entrance test or admit students based on UPSEE/UPCET or other entrance exams.
Career Scope After BTech in Biotechnology
The career opportunities after graduating from one of the top BTech Biotechnology colleges in Lucknow are broad and expanding. Graduates can work in:
Pharmaceutical companies – in R&D, production, and quality control
Biotech firms – as research scientists, lab technicians, or project managers
Agricultural industries – working on genetically modified crops or pest-resistant seeds
Healthcare and diagnostics – especially in developing diagnostic kits or vaccines
Environmental firms – tackling waste management, pollution control, and bio-remediation
Higher education and research – pursuing MTech, MSc, or PhD in India or abroad
Some of the top recruiters include Biocon, Serum Institute, Cipla, Panacea Biotech, and Indian government research bodies like CSIR, ICMR, and DBT.
Final Thoughts
Whether you’re aiming to start fresh or looking for the best lateral entry BTech college in Lucknow, biotechnology remains one of the most dynamic and future-proof engineering disciplines. With a strong base of BTech Biotech colleges in Lucknow and growing industry relevance, now is a smart time to enter the field.
Make sure to check college accreditations, faculty profiles, lab infrastructure, and placement records when making your decision. Lucknow offers the education, exposure, and ecosystem you need to turn your biotech dreams into reality.
0 notes
Text

day 11 // 100doc && day 26 // 100dop
2/4 practice problems but i think my solution for 1 of them could cause a segmentation error so i wanna rework it... also, it's very hard to code at all when i'm sleepy...i keep running into stupid errors. For example, this function:
Originally it said return i; in the if statement. Well, it would only return i and not run return price (which originally used i directly). But if I moved return menu[i].price; into the if statement, and have no other return, it errors because the function is supposed to return *something*...and the return apparently has to be outside the if statement and for loop... This has happened before and I was able to fix it... But for the life of me, I could not remember how to fix it for this problem. It's discouraging. But...I'm just sleepy...I hope that's the only reason I keep making silly mistakes 😅 Also, yes, I write very stupidly basic comments to myself when I'm sleepy...and sometimes even when I'm not sleepy.
found an intro to bioinformatics course online last night but i need to know some stats for that, so i started stat 110x today (i'm auditing it, so i lose access on Aug 31, i hope i'll be able to finish it alongside chem and cs50x...)
read
piano
#thanks unsplash#dark academia#dark academic aesthetic#codeblr#minimalist#progblr#100 days of code#cs50#100dop#100 days of productivity#astudentslifebuoy#stemblr#studyblr
9 notes
·
View notes
Text
Quobly Launches High-Fidelity Quantum Emulator with QPerfect

Quobly
Quobly, a quantum microelectronics leader, launched a major software emulator that emulates quantum circuits on classical devices. Developers, researchers, and industry experts may now build and test quantum algorithms on this “perfect” emulator, demonstrated at the France Quantum event and produced with French emulation startup QPerfect. Its immediate accessibility on OVHcloud shows its real-world readiness. This announcement is a major step in Quobly's industrialisation strategy, which includes an exclusive agreement with STMicroelectronics to advance from emulation to commercial quantum hardware.
The emulator is “perfect” since it does not simulate qubit physical defects and can emulate 27 to 31 logical qubits without errors. This stability is needed for accurate algorithm training and testing. The emulator employs QPerfect's language, akin to IBM's Qiskit and Google's Cirq. This strategy simplifies user training and integration by eliminating the need for a proprietary language and ensuring widespread accessibility.
Combinatorial optimisation, notably in commercial logistics, quantum chemistry for materials discovery, and quantitative finance for portfolio management all address concrete needs across significant sectors, making the emulation helpful. It also enhances artificial intelligence, medicinal development, and deep learning. The tool is also used for bioinformatics and defence training and demonstrations, where it has a commercial agreement with the Direction Générale des Armées. Its stable environment encourages public and commercial organisations to participate early, creating quantum readiness before actual machines operate.
The first major release of an ambitious software package is this “perfect” emulator. Future versions will leverage tensor networks and accurate hardware defect and quantum noise modelling to mimic up to 100 qubits.
An exclusive partnership with STMicroelectronics at the end of 2024 integrates the launch into Quobly's industrialisation strategy. This alliance allows large-scale quantum computing systems using STMicroelectronics' 28nm FD-SOI semiconductor volume manufacturing processes. Quobly can control the entire value chain and build a complete ecosystem from software to hardware by adding industrial manufacturing limits into design. This integrated strategy gives a competitive edge in the fast-growing quantum sector.
According to Quobly CEO and co-founder Maud Vinet, “This emulator accelerates the development of the quantum machine and comes before its production.” Emulation tools aid system design and hardware performance in traditional integrated circuit development, she said. “A powerful tool for preparing the transition to scale with the customers,” Vinet said, emphasising its role in preparing clients for growth. She credited this magnitude of industrialisation planning to the “unique partnership with STMicroelectronics.”
Quobly's emulator connects quantum gear's future possibilities to traditional computer. Quobly provides an accurate and easy-to-use environment for developing and testing quantum algorithms, nurturing the knowledge and application foundation essential for quantum computer adoption. This accelerates theoretical potential to quantum solutions.
In Conclusion
According to the material, Quobly has produced a “perfect” quantum emulator for testing quantum algorithms on classical hardware. QPerfect helped design this emulator. It supports 27 to 31 logical qubits without simulated physical faults and works with IBM's Qiskit and Google's Cirq. To prepare defence, banking, logistics, and pharmaceutical industries for quantum computing. This introduction is the first stage in Quobly's software suite and industrialisation strategy with STMicroelectronics to move from emulation to commercial quantum hardware. The initiative takes a measured step to accelerate quantum preparation and bridge the gap between classical computer and quantum capabilities.
#Quobly#quantumalgorithms#OVHcloud#quantumhardware#deeplearning#qubits#artificialintelligence#quantumcomputing#IBMQiskit#News#Technews#Technology#Technologynews#Technologytrends#Govindhtech
1 note
·
View note
Text
Global Metagenomic Sequencing Market is driven by Technological Advances

Metagenomic sequencing platforms enable comprehensive analysis of genetic material directly from environmental or clinical samples, bypassing the need for traditional culturing methods. These products include high-throughput DNA sequencers, library preparation kits, and bioinformatics software tailored for microbiome profiling, pathogen detection, and biodiversity assessment. Advantages such as unbiased community profiling, rapid turnaround times, and scalable workflows make metagenomic sequencing indispensable for research institutions, pharmaceutical developers, and diagnostic laboratories. The ability to detect novel organisms and antimicrobial resistance genes directly influences drug discovery, public health surveillance, and agricultural biosecurity initiatives. Growing concerns over emerging infectious diseases and the quest for precision medicine have intensified the need for Global Metagenomic Sequencing Market, driving investments in improved sample prep and cloud-based analytics. Ongoing market research into enhanced read lengths and error correction methods further bolsters confidence in metagenomic data for regulatory submissions. As sequencing costs decline and data interpretation tools mature, adoption is expanding across clinical and environmental applications, reshaping the industry’s market dynamics and enabling businesses to capture greater market share. Global metagenomic sequencing market size is expected to reach US$ 6.16 Bn by 2032, from US$ 1.96 Bn in 2025, exhibiting a compound annual growth rate (CAGR) of 17.8% during the forecast period.Key Takeaways Key players operating in the Global Metagenomic Sequencing Market are: -Illumina-QIAGEN-Thermo Fisher Scientific-Oxford Nanopore Technologies-BGI GroupThese market players leverage robust R&D pipelines to introduce next-generation sequencing instruments, advanced sample prep solutions, and AI-driven analysis software. Illumina’s NovaSeq series, QIAGEN’s QIAseq kits, Thermo Fisher’s Ion Torrent systems, Oxford Nanopore’s MinION platform, and BGI Group’s DNBSEQ instruments exemplify the competitive landscape. Through strategic collaborations, acquisitions, and co-development agreements, these companies aim to extend their product portfolios and strengthen service offerings. Their efforts are guided by comprehensive market research and detailed market reports, ensuring that portfolio expansions align with evolving customer demands and regulatory requirements. Continuous innovation in sequencing chemistries and data compression algorithms supports sustained revenue growth and reinforces their leading positions in the global industry.Rising awareness of the human microbiome’s role in health and disease is driving strong demand for metagenomic sequencing services. Healthcare providers and researchers seek detailed microbial profiles to inform personalized treatment plans, monitor therapeutic interventions, and detect pathogens in real time. Similarly, agricultural and environmental sectors adopt metagenomic workflows to optimize crop yields, assess soil health, and track pollutant-degrading bacteria. The convergence of big data analytics with advanced sample processing has unlocked new market opportunities across pharmaceuticals, diagnostics, and ecology. Growing investments in microbiome-based therapeutics and probiotic formulations further ignite demand.
‣ Get More Insights On: Global Metagenomic Sequencing Market
‣ Get this Report in Japanese Language: 世界のメタゲノムシーケンシング市場
‣ Get this Report in Korean Language: 글로벌메타게놈시퀀싱시장
‣ Resources- Global Metagenomic Sequencing: Unlocking the Secrets of Microbial Communities
0 notes
Text
Best Biotechnology Companies in Kerala to Start Your Career
Are you a biotechnology enthusiast looking to kick-start your career? Then Kerala, with its booming life sciences sector, is the right place to begin. The state is home to many innovative research institutions and fast-growing biotech startups. If you're serious about your future, choosing the right biotechnology company in Kerala can make all the difference.
Why Kerala Is Becoming a Biotech Hub
Kerala’s supportive ecosystem, talented pool of professionals, and focus on healthcare and agriculture have made it an ideal location for a biotechnology company in Kerala to thrive. With government incentives and international collaborations, this region is emerging as one of India's leading biotech destinations.
Top Reasons to Work at a Biotechnology Company in Kerala
Cutting-edge research opportunities: A biotechnology company in Kerala often collaborates with universities and global institutions, offering exposure to advanced techniques.
Work-life balance: Kerala offers a quality lifestyle that complements the dynamic work environments of a biotechnology company in Kerala.
Career growth: Whether you're into molecular biology, genomics, or diagnostics, a biotechnology company in Kerala provides vertical and lateral growth opportunities.
Skills in Demand
If you're planning to work in a biotechnology company in Kerala, here are some valuable skills:
Molecular Diagnostics
PCR & qPCR Technologies
Genomic Data Analysis
Microbial Culturing Techniques
Bioinformatics
Having a strong foundation in these areas will make you an asset to any biotechnology company in Kerala.
Vetagenomics – A Trusted Name in Kerala’s Biotech Landscape
Among all, Vetagenomics stands out as a premier biotechnology company in Kerala. Specializing in molecular diagnostics, microbial testing, and DNA-based solutions, Vetagenomics is known for its innovation and excellence in service delivery.
Joining a reputed biotechnology company in Kerala like Vetagenomics means learning from the best and working on projects that have real-world impact.
Internships & Training Opportunities
If you're a student or a recent graduate, many biotechnology companies in Kerala offer internships and hands-on training. This early exposure to lab protocols and industrial workflows is essential for your resume and future success.
Explore internship programs at a top biotechnology company in Kerala to gain insights into research methods, data handling, and industry compliance standards.
How to Apply
To work with a leading biotechnology company in Kerala, update your resume with relevant skills, showcase your academic projects, and be ready to learn continuously. Visit career pages, attend local biotech events, and follow LinkedIn updates to spot job openings.
Final Thoughts
A biotechnology company in Kerala offers more than just a job—it offers a career with purpose. With sectors like healthcare, agriculture, and environmental biotechnology rapidly expanding, there's never been a better time to be part of this thriving ecosystem.
If you're passionate about science and want to make a meaningful difference, now is the time to align your goals with the right biotechnology company in Kerala. Begin your journey today, and contribute to the future of global biotechnology right from Kerala.
0 notes
Text
Tumor Transcriptomics Market Size, Share, Trends, Demand, Growth and Competitive Analysis
Executive Summary Tumor Transcriptomics Market:
This international Tumor Transcriptomics Market business report includes strategic profiling of key players in the market, systematic analysis of their core competencies, and draws a competitive landscape for the market. It is the most appropriate, rational and admirable market research report provided with a devotion and comprehension of business needs. The report also estimates CAGR (compound annual growth rate) values along with its fluctuations for the definite forecast period. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the market has also been included in this market report. It all together leads to the company’s growth, by subsidizing the risk and improving the performance.
Competitive landscape in this report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and strategies. According to this Tumor Transcriptomics Market report, the global market is anticipated to witness a moderately higher growth rate during the forecast period. This Tumor Transcriptomics Market report is structured with the clear understanding of business goals of industry and needs to bridge the gap by delivering the most appropriate and proper solutions. Businesses can confidently rely on the information mentioned in this Tumor Transcriptomics Market report as it is derived only from the important and genuine resources.
Discover the latest trends, growth opportunities, and strategic insights in our comprehensive Tumor Transcriptomics Market report. Download Full Report: https://www.databridgemarketresearch.com/reports/global-tumor-transcriptomics-market
Tumor Transcriptomics Market Overview
**Segments**
- **By Product Type**: The tumor transcriptomics market can be segmented into instruments, consumables, and services. Instruments include PCR machines, microarray equipment, and sequencing platforms. Consumables consist of reagents, RNA extraction kits, and assay kits. Services cover gene expression profiling, data analysis, and consulting services.
- **By Cancer Type**: This market segment is categorized into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. Each cancer type may require specific transcriptomic analysis for targeted therapies and personalized medicine.
- **By End-User**: The tumor transcriptomics market can be further divided into hospitals, cancer research centers, diagnostic laboratories, and pharmaceutical companies. Different end-users have varying needs for transcriptomic tools and services.
- **By Region**: Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each region has its own set of regulations, healthcare infrastructure, and adoption rates for tumor transcriptomics technology.
**Market Players**
- **Illumina, Inc.**: One of the key players in the tumor transcriptomics market, Illumina offers sequencing platforms and related services for cancer research and diagnostics.
- **Thermo Fisher Scientific Inc.**: This company provides a wide range of consumables and instruments for tumor transcriptomics analysis, catering to the needs of researchers and healthcare professionals.
- **Agilent Technologies**: Known for its microarray platforms and assay kits, Agilent Technologies is a major player in the global tumor transcriptomics market, offering solutions for gene expression profiling.
- **QIAGEN N.V.**: QIAGEN specializes in RNA extraction kits and bioinformatics tools essential for tumor transcriptomics, enabling researchers to analyze gene expression patterns in cancer.
- **Fluidigm Corporation**: With its innovative microfluidic technology, Fluidigm Corporation offers high-throughput solutions for single-cell analysis and gene expression studies in tumors.
The global tumor transcriptomics market is witnessing significant growth due to the rising prevalence of cancer worldwide and the increasing demand for precision medicine. Advancements in transcriptomic technologies, such as next-generation sequencing and microarray analysis, have enabled researchers to study gene expression patterns in tumors with high accuracy and throughput. Key market players are investing in product development, strategic collaborations, and expansion initiatives to capitalize on the growing opportunities in this market. As personalized medicine gains momentum, the use of tumor transcriptomics for patient stratification and treatment selection is expected to drive further market growth.
Market players such as Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, QIAGEN N.V., and Fluidigm Corporation are at the forefront of developing cutting-edge solutions for tumor transcriptomics. These companies offer a wide range of instruments, consumables, and services that cater to the diverse needs of hospitals, cancer research centers, diagnostic laboratories, and pharmaceutical companies. By focusing on product development and strategic collaborations, these key players are driving innovation in the market and expanding their global footprint.
In addition to technological advancements, the market is also influenced by regulatory landscapes and healthcare infrastructure in different regions. North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa each have unique market dynamics that shape the adoption and growth of tumor transcriptomics technology. Market players must navigate these regional differences to effectively penetrate local markets and capitalize on the growing demand for precision medicine solutions.
Advancements in transcriptomic technologies, such as next-generation sequencing, microarray analysis, and RNA extraction kits, have revolutionized the way researchers study gene expression patterns in tumors. This enhanced accuracy and throughput have paved the way for more precise cancer treatments, driving the demand for transcriptomic analysis tools and services across different cancer types. The shift towards personalized medicine, which relies heavily on tumor transcriptomics to identify specific gene expression patterns for tailored treatment decisions, is a key trend shaping the market dynamics.
Furthermore, while technological innovation remains a key driver of market growth, regional dynamics also play a crucial role in shaping the adoption and expansion of tumor transcriptomics technology. Different regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa have unique regulatory landscapes and healthcare infrastructures that impact market dynamics. Market players must navigate these regional differences effectively to tap into local markets and capitalize on the increasing demand for precision medicine solutions.
Looking ahead, the global tumor transcriptomics market is expected to maintain its upward trajectory as the emphasis on personalized medicine grows and the need for targeted therapies for different cancer types intensifies. Researchers and healthcare professionals are increasingly relying on transcriptomic analysis to gain a better understanding of cancer biology and develop innovative treatment strategies. Key market players will continue to drive innovation through strategic initiatives such as product launches, collaborations, and mergers, reinforcing their position in this competitive and rapidly evolving market landscape.
The Tumor Transcriptomics Market is highly fragmented, featuring intense competition among both global and regional players striving for market share. To explore how global trends are shaping the future of the top 10 companies in the keyword market.
Learn More Now: https://www.databridgemarketresearch.com/reports/global-tumor-transcriptomics-market/companies
DBMR Nucleus: Powering Insights, Strategy & Growth
DBMR Nucleus is a dynamic, AI-powered business intelligence platform designed to revolutionize the way organizations access and interpret market data. Developed by Data Bridge Market Research, Nucleus integrates cutting-edge analytics with intuitive dashboards to deliver real-time insights across industries. From tracking market trends and competitive landscapes to uncovering growth opportunities, the platform enables strategic decision-making backed by data-driven evidence. Whether you're a startup or an enterprise, DBMR Nucleus equips you with the tools to stay ahead of the curve and fuel long-term success.
Regional Analysis/Insights
The Tumor Transcriptomics Market is analyzed and market size insights and trends are provided by country, component, products, end use and application as referenced above.
The countries covered in the Tumor Transcriptomics Market reportare U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominatesthe Tumor Transcriptomics Market because of the region's high prevalence Tumor Transcriptomics Market
Asia-Pacific is expectedto witness significant growth. Due to the focus of various established market players to expand their presence and the rising number of surgeries in this particular region.
Browse More Reports:
Global Respiratory Syncytial Virus Treatment Market Global Resorcinol Market Global Refrigerated Vending Machine Market Global Recliner Sofas Market Global Railway Operation Management Market Global Radio Frequency (RF) Components Market Global Rabies Diagnostics Market Global PVC Additives Market Global Puerperal Sepsis Treatment Market Global Pregnancy Pillow Market Global Power Inductor Market Global Powdered Seaweed Market Global Potassium carbonate Market Global Portable Fabric Canopies Market Global Polyurethane Foam Market Global Polysulfide Market Global Polyoxymethylene (POM) Market Global Polyolefin Market Global Polyethylene Terephthalate (PET) Stretch Blow Molding Machines Market Global Polyethylene (PE) Foam Film Market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975 Email:- [email protected]
Tag
Tumor Transcriptomics Market Size, Tumor Transcriptomics Market Share, Tumor Transcriptomics Market Trend, Tumor Transcriptomics Market Analysis, Tumor Transcriptomics Market Report, Tumor Transcriptomics Market Growth, Latest Developments in Tumor Transcriptomics Market, Tumor Transcriptomics Market Industry Analysis, Tumor Transcriptomics Market Key Player, Tumor Transcriptomics Market Demand Analysis
0 notes